Clinical Trials Browser

Phase 1 × Recurrence × elotuzumab × Clear all

NCT03023527 2018-05-23

Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma

Phase 1 Terminated

Multiple Myeloma, Recurrence